Announces New Content on the 2012 Stryker Hip Implant Recall and Lawsuits

Share Article

In the wake of Stryker Corporation's recall of its Rejuvenate and ABGIII hip implant models, many patients facing painful revision surgery have questions about whether or not the defects leading to the recall could have been detected prior to release. Stryker bypassed FDA pre-market testing before selling the latest implants, and newly filed lawsuits allege the company's implants caused patient injury.

Litigation will likely investigate whether or not Stryker could have prevented the problems before distributing its implants

Free Advice announces new articles providing information about the 2012 Stryker Hip Implant recall and corresponding lawsuits. The FDA posted notice of the Rejuvenate and ABGII implants recall, and Free Advice provides informative content on both the recall and corresponding legal action.

Defects With Stryker Implants Led to Lawsuits

Free Advice's new content discusses lawsuits such as the ones filed by 10 plaintiffs across New Jersey who requested consolidation of cases against Stryker Corporation due to complications from its defective Rejuvenate and ABGII hip implants. Case numbers (all preceded with BER-L): 006886-12, 006888-12, 006880-12, 006879-12, 006884-12, 006878-12, 006992-12, 005993-12 have joined with two others yet to be assigned numbers in a lawsuit seeking damages for injuries suffered after receiving Rejuvenate and ABGII hip implants. The plaintiffs requested the New Jersey Supreme Court to move all 10 cases to the Bergen County Superior Court.

According to their request to consolidate cases, the New Jersey plaintiffs allegedly suffered from metal-on-metal friction caused by metal portions of the implant neck coming into contact with the metal coated implant stem, causing metal fragments to release into the surrounding tissue. The metal-on-metal friction in the Rejuvenate and ABGII hip implants resulted in implant failure and a condition known as metallosis which led the company to issue a voluntary recall of the products in June of 2012.

The lawsuits allege that defects in Stryker’s hip implants created painful problems for the New Jersey plaintiffs that would require revision surgery, and the resulting litigation will likely investigate whether or not Stryker could have prevented the problems before distributing its implants. Find further information at on how Stryker’s Rejuvenate and ABGII models failed.

Stryker Was Exempted from FDA Testing

Typically, before a new medical device or product enters the market, the United States Food and Drug Administration requires pre-market testing to ensure consumer safety. However, Stryker was able to circumvent FDA testing by receiving a 510(k) exception to pre-market testing. A 510(k) exception allows manufacturers to release products that compare favorably to others already on the market, without pre-market testing.

Stryker is not the only company to avoid FDA testing under the 510(k) exception, however, if the lawsuits against Stryker determine that use of the exception contributed to the failure to detect the defects in its Rejuvenate and ABGII models, the company could be forced to pay significant judgments to injured patients. Find a complete write up on Stryker’s use of the 510(k) exception, and how it impacted the distribution and sale of the Rejuvenate and ABGII models, at

Important Issues in the Stryker Hip Implant Lawsuits

The New Jersey plaintiffs allegedly injured by the new Stryker hip implants face painful surgery to repair or replace the implant, and need to undergo a longer than normal rehabilitation process. Other patients across the country with similar injuries may also be eligible to file lawsuits against Stryker after receiving Rejuvenate and ABGII hip implants. These cases may result in verdicts awarding major damages, or large settlements to compensate the patients and their families.

Further, if juries or judges can be convinced that the defects in the hip implants, and the subsequent pain suffered by patients, could have been avoid with normal pre-market testing, Stryker may be liable to patients for significant damages in addition to the medical costs that arose due to the products’ defects.

Contact an Attorney

If you or a loved one has a Stryker Rejuvenate hip implant or a Stryker ABGII hip implant, there is a meaningful possibility of implant failure and painful revision surgery. In order to determine if you may be eligible to recover the compensation you deserve from the manufacturer of the Stryker Rejuvenate and ABGII hip implants, the advice of an experienced attorney is essential.

Most attorneys handling product defect cases work on a contingency fee basis, advancing all fees and costs, and being paid only from the proceeds they help you recover from a settlement or trial. As there are strict time limits for filing claims, which vary by state, it is particularly important to review the possibility of a claim related to the Stryker Rejuvenate and ABGII hip implants quickly. To connect with one or more of the law firms that handles these claims on a nationwide basis, click here.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brandon Brown
Follow us on
Visit website